陈列药和甲状腺眼病 (TED):一个系统性审查
Ramin Malboosbaf1, Zohreh Maghsoomi2, Zahra Emami1
1Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
Endocrine
|January 9, 2024
概括
药物可能有助于预防和治疗甲状腺眼病 (TED),这是格雷夫斯病 (GD) 的并发症. 这次审查发现了证据表明,他类药物的使用可以延迟TED发作并改善治疗反应.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲状腺眼病 (TED) 是格雷夫斯病 (GD) 的一种显著的甲状腺外表现. 目前对TED的治疗有局限性,不能完全预防长期并发症.
- 由于现有治疗方法的缺陷,对TED有效的预防和治疗策略的需求至关重要.
研究的目的:
- 系统地审查关于他类药物在预防和治疗甲状腺眼病 (TED) 疗效的现有证据.
主要方法:
- 在多个数据库 (Medline,Scopus,Web of Science,ProQuest,Cochrane Library) 进行了全面的文献搜索,截至2023年9月.
- 研究是根据PRISMA指导方针进行选择的,数据提取和质量评估由两位研究人员独立进行.
- 在观察性研究中使用纽卡斯尔-太华尺度 (NOS) 评估研究质量,在随机临床试验中使用柯克莱恩偏差风险工具 (RoB2).
主要成果:
- 四项研究 (三项追溯队列,一项RCT) 符合纳入标准.
- 回顾性研究表明,他类药物可以预防或延迟TED,特别是在男性和更长的治疗时间,降低TED风险高达40%.
- 一个RCT表明,当阿托瓦斯塔丁被添加到IVGC时,对中度至重度的活性TED的治疗反应得到改善,没有显著的副作用,并且在严重的情况下减少了重建性手术的需要.
结论:
- 达丁类药物治疗显示出作为预防和管理甲状腺眼病 (TED) 的辅助治疗的前景.
- 进一步的研究可能会巩固他类药物在TED多式联络管理中的作用.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
664
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
664
Synthesis and Regulation of Thyroid Hormones
4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
Open Angle Glaucoma: Treatment
453
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
453
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K


